3M Company (NYSE:MMM) ended the last trading day at $167.53. Company weekly volatility is calculated as 1.21% and price to cash ratio as 52.98. 3M Company (NYSE:MMM) showed a weekly performance of 1.87%.
3M Company (NYSE:MMM) has recently announced its five-year financial objectives, and explained how it will be in a position to deliver strong performance this year, and beyond. The company also reaffirmed its fiscal year 2016 (FY16) guidance.
Total System Services, Inc. (NYSE:TSS) ended the last trading day at $48.50. Company weekly volatility is calculated as 2.26% and price to cash ratio as 22.82. Total System Services, Inc. (NYSE:TSS) showed a weekly performance of 5.48%.
Total System Services, Inc. (NYSE:TSS) announced it has completed its acquisition of TransFirst, a leading U.S. merchant solutions provider. TransFirst and TSYS’ existing merchant businesses will be combined under the TSYS brand to create the 6th largest merchant acquirer in the U.S. based on revenue and the 3rd largest integrated payments provider in the U.S. TransFirst’s president and chief executive officer, John Shlonsky, has been elected as Senior Executive Vice President of TSYS, and will lead the combined businesses reporting to Pam Joseph, president and chief operating officer-elect of TSYS.
Waterstone Financial, Inc. (NASDAQ:WSBF) declared a quarterly dividend. Investors of record on Tuesday, April 12th will be given a dividend of 0.05 per share on Monday, May 2nd. This represents a $0.20 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date is Friday, April 8th.
On 01 April, Waterstone Financial, Inc. (NASDAQ:WSBF) shares increased 2.63% and was closed at $14.04. WSBF EPS growth in last 5 year was 67.50%. Waterstone Financial, Inc. (NASDAQ:WSBF) year to date (YTD) performance is -0.43%.
Halozyme Therapeutics, Inc. (NASDAQ:HALO) shares increased 2.96% in last trading session and ended the day at $9.75. HALO Gross Margin is 78.40% and its has a return on assets of -19.20%. Halozyme Therapeutics, Inc. (NASDAQ:HALO) quarterly performance is -44.03%.
Halozyme Therapeutics, Inc. (NASDAQ:HALO) will present preclinical data from five studies at the American Association of Cancer Research (AACR) annual conference next month, including results from its ongoing research of lead investigational agent, PEGPH20, and two novel pipeline assets engineered for increased action in the tumor microenvironment. The AACR annual conference will take place April 17-20 in New Orleans.
Anavex Life Sciences Corp. (NASDAQ:AVXL) caters to the Healthcare space. Its performance is 8.64%. On the last day of trading company shares ended up at $5.03.
Anavex Life Sciences Corp (NASDAQ:AVXL)‘s stock had its “buy” rating reissued by equities researchers at Maxim Group in a report released on Friday, Market Beat Ratings reports. They currently have a $15.00 price target on the stock. Maxim Group’s target price would suggest a potential upside of 225.38% from the company’s current price.
Leave a Reply